What is Physicians' Research Options?
Operating as a specialized clinical research organization, Physicians' Research Options leverages over six decades of collective staff expertise to manage high-stakes medical trials. The company maintains a robust footprint across Utah, Nevada, and Colorado, utilizing a mature network of dedicated clinical investigators. Their operational model integrates comprehensive regulatory, administrative, and clinical coordination, ensuring that both pharmaceutical sponsors and medical device manufacturers receive high-fidelity data. By focusing on patient-centric trial management, the firm has established itself as a critical partner in the drug development lifecycle, bridging the gap between laboratory innovation and regulatory approval.
How much funding has Physicians' Research Options raised?
Physicians' Research Options has raised a total of $114K across 1 funding round:
Debt
$114K
Debt (2021): $114K with participation from PPP
Key Investors in Physicians' Research Options
PPP
Public-Private Partnership
What's next for Physicians' Research Options?
With the recent capital deployment, Physicians' Research Options is positioned to scale its investigative capacity and enhance its technological integration for trial management. The strategic focus will likely shift toward expanding the geographic reach of its clinical sites and optimizing the recruitment pipeline for specialized patient populations. As the clinical research landscape becomes increasingly competitive, the firm's ability to maintain high-quality data standards while accelerating trial timelines will be paramount. This late-stage financing provides the necessary runway to invest in advanced regulatory compliance tools and administrative automation, ensuring the company remains a preferred partner for global life sciences entities seeking reliable, high-volume clinical trial execution.
See full Physicians' Research Options company page
